Get my own profile
Public access
View all38 articles
2 articles
available
not available
Based on funding mandates
Co-authors
- JA LedermannProfessor of medical oncology, UCL Cancer InstituteVerified email at ucl.ac.uk
- Prof Richard S KaplanMRC Clinical Trials Unit at University College LondonVerified email at ucl.ac.uk
- Cervantes AProfessor of Medicine. University of ValenciaVerified email at uv.es
- Mark LansdownVerified email at leedsth.nhs.uk
- Iain McNeishProfessor of Oncology, Department of Surgery and Cancer, Imperial College LondonVerified email at imperial.ac.uk
- Robert ColemanUniversity of SheffieldVerified email at sheffield.ac.uk
- James PaulUniversity of GlasgowVerified email at glasgow.ac.uk
- Jeff EvansProfessor of Translational Cancer Research, Director of Institute of Cancer Sciences, University ofVerified email at glasgow.ac.uk
- Douglas EastonProfessor of Genetic Epidemiology, University of CambridgeVerified email at medschl.cam.ac.uk
- david wyldDirector Medical Oncology Royal Brisbane and Womens HospitalVerified email at health.qld.gov.au
- Anne LanceleyProfessor of Women's Cancer CareVerified email at ucl.ac.uk
- Johnson PWProfessor of Medical Oncology, University of SouthamptonVerified email at soton.ac.uk
- Richard SainsburyUniversity College LondonVerified email at ucl.ac.uk
- David CunninghamThe Royal Marsden NHS Foundation TrustVerified email at rmh.nhs.uk
- Lesley J. FallowfieldDirector SHORE-C, University of SussexVerified email at sussex.ac.uk
- Peter SimmondsUniversity of OxfordVerified email at ndm.ox.ac.uk
Follow
Timothy PERREN
Consultant Medical Oncologist, Leeds teaching Hospitals NHS Trust
Verified email at leeds.ac.uk